Cargando…

Follow-up imaging after cryoablation of clear cell renal cell carcinoma is feasible using single photon emission computed tomography with (111)In-girentuximab

PURPOSE: Detection of residual or recurrent vital renal tumor on follow-up (FU) cross-sectional imaging after ablative therapy is challenging. The specific and high expression levels of carbonic anhydrase IX (CAIX) in clear cell renal cell carcinoma (ccRCC) makes it a suitable target for imaging usi...

Descripción completa

Detalles Bibliográficos
Autores principales:	van Oostenbrugge, Tim J., Langenhuijsen, Johan F., Oosterwijk, Egbert, Boerman, Otto C., Jenniskens, Sjoerd F., Oyen, Wim J. G., Fütterer, Jurgen J., Mulders, Peter F. A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2019
Materias:	Short Communication
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7299921/ https://www.ncbi.nlm.nih.gov/pubmed/31768601 http://dx.doi.org/10.1007/s00259-019-04613-z

Ejemplares similares

Tumor-targeted Dual-modality Imaging to Improve Intraoperative Visualization of Clear Cell Renal Cell Carcinoma: A First in Man Study
por: Hekman, Marlène C., et al.
Publicado: (2018)

Intraoperative MRI-derived volumetric ablation margins and initial correlation with local outcome after MRI-guided cryoablation of renal tumors
por: de Jager, Nienke S., et al.
Publicado: (2023)

Successful Combination of Sunitinib and Girentuximab in Two Renal Cell Carcinoma Animal Models: A Rationale for Combination Treatment of Patients with Advanced RCC
por: Oosterwijk-Wakka, Jeannette C., et al.
Publicado: (2015)

Antibody therapy in renal cell carcinoma
por: Oosterwijk, Egbert, et al.
Publicado: (2008)

Radiolabeled antibodies in renal cell carcinoma
por: Stillebroer, Alexander B., et al.
Publicado: (2007)

Phase I study to assess safety, biodistribution and radiation dosimetry for (89)Zr-girentuximab in patients with renal cell carcinoma
por: Merkx, Robin I. J., et al.
Publicado: (2021)

Validation of a Web-Based Planning Tool for Percutaneous Cryoablation of Renal Tumors
por: van Oostenbrugge, Tim J., et al.
Publicado: (2020)

[(89)Zr]Zr-DFO-girentuximab and [(18)F]FDG PET/CT to Predict Watchful Waiting Duration in Patients with Metastatic Clear-cell Renal Cell Carcinoma
por: Verhoeff, Sarah R., et al.
Publicado: (2023)

Application of Monoclonal Antibody G250 Recognizing Carbonic Anhydrase IX in Renal Cell Carcinoma
por: Oosterwijk-Wakka, Jeannette C., et al.
Publicado: (2013)

Lesion detection by [(89)Zr]Zr-DFO-girentuximab and [(18)F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma
por: Verhoeff, Sarah R., et al.
Publicado: (2019)

Potential role of (124)I-girentuximab in the presurgical diagnosis of clear-cell renal cell cancer
por: Smaldone, Marc C, et al.
Publicado: (2012)

Percutaneous MR-guided focal cryoablation for recurrent prostate cancer following radiation therapy: retrospective analysis of iceball margins and outcomes
por: Overduin, Christiaan G., et al.
Publicado: (2017)

Evaluation of Radiolabeled Girentuximab In Vitro and In Vivo
por: Basaco, Tais, et al.
Publicado: (2018)

MRI-Guided Salvage Focal Cryoablation: A 10-Year Single-Center Experience in 114 Patients with Localized Recurrent Prostate Cancer
por: Wimper, Yvonne, et al.
Publicado: (2023)

Improved labelling of DTPA- and DOTA-conjugated peptides and antibodies with (111)In in HEPES and MES buffer
por: Brom, Maarten, et al.
Publicado: (2012)

Combination of sunitinib and (177)Lu-labeled antibody cG250 targeted radioimmunotherapy: A promising new therapeutic strategy for patients with advanced renal cell cancer
por: Oosterwijk-Wakka, Jeannette C., et al.
Publicado: (2022)

(111)In-exendin Uptake in the Pancreas Correlates With the β-Cell Mass and Not With the α-Cell Mass
por: Brom, Maarten, et al.
Publicado: (2015)

(111)In-anti-F4/80-A3-1 antibody: a novel tracer to image macrophages
por: Terry, Samantha Y. A., et al.
Publicado: (2015)

Diagnostic Imaging for Solid Renal Tumors: A Pictorial Review
por: van Oostenbrugge, Tim J., et al.
Publicado: (2018)

STARLITE 1: Phase 1b/2 study of combination 177Lu girentuximab plus cabozantinib and nivolumab in treatment naïve patients with advanced clear cell RCC
por: Hasanov, Elshad, et al.
Publicado: (2023)

MRI as a tool to assess surgical margins and pseudocapsule features directly following partial nephrectomy for small renal masses
por: van Oostenbrugge, Tim J., et al.
Publicado: (2018)

Fatty acid binding protein 7 may be a marker and therapeutic targets in clear cell renal cell carcinoma
por: Nagao, Kazuhiro, et al.
Publicado: (2018)

Molecular Profiling of Druggable Targets in Clear Cell Renal Cell Carcinoma Through Targeted RNA Sequencing
por: van den Heuvel, Corina N. A. M., et al.
Publicado: (2019)

Comparative biodistribution of 12 (111)In-labelled gastrin/CCK2 receptor-targeting peptides
por: Laverman, Peter, et al.
Publicado: (2011)

Nuclear medicine imaging and therapy of neuroendocrine tumours
por: Gotthardt, Martin, et al.
Publicado: (2006)

Radiolabelled peptides for oncological diagnosis
por: Laverman, Peter, et al.
Publicado: (2012)

Yield of Repeat Targeted Direct in-Bore Magnetic Resonance-Guided Prostate Biopsy (MRGB) of the Same Lesions in Men Having a Prior Negative Targeted MRGB
por: Venderink, Wulphert, et al.
Publicado: (2018)

Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging
por: Hekman, Marlène C. H., et al.
Publicado: (2017)

(68)Ga-labelled exendin-3, a new agent for the detection of insulinomas with PET
por: Brom, Maarten, et al.
Publicado: (2010)

Characterization of (111)In-labeled Glucose-Dependent Insulinotropic Polypeptide as a Radiotracer for Neuroendocrine Tumors
por: Willekens, Stefanie M. A., et al.
Publicado: (2018)

Recent progress in cryoablation cancer therapy and nanoparticles mediated cryoablation
por: Kwak, Kijung, et al.
Publicado: (2022)

Case report: Local cryoablation combined with pembrolizumab to eliminate lung metastases from ovarian clear cell carcinoma
por: Meng, Liangliang, et al.
Publicado: (2022)

Nano-pulse stimulation™ therapy (NPS™) is superior to cryoablation in clearing murine melanoma tumors
por: McDaniel, Amanda, et al.
Publicado: (2023)

Percutaneous Cryoablation for Renal Cell Carcinoma
por: Maria, Tsitskari, et al.
Publicado: (2015)

Albumin-derived peptides efficiently reduce renal uptake of radiolabelled peptides
por: Vegt, Erik, et al.
Publicado: (2009)

Pretargeted Imaging and Radioimmunotherapy of Cancer Using Antibodies and Bioorthogonal Chemistry
por: van de Watering, Floor C. J., et al.
Publicado: (2014)

Cryoablation and immunotherapy: an overview of evidence on its synergy
por: Aarts, B. M., et al.
Publicado: (2019)

Immune Effects of Cryoablation in Woodchuck Hepatocellular Carcinoma
por: Mauda-Havakuk, Michal, et al.
Publicado: (2023)

Zirconium-89 Labeled Antibodies: A New Tool for Molecular Imaging in Cancer Patients
por: van de Watering, Floor C. J., et al.
Publicado: (2014)

Immunotherapy response evaluation with (18)F-FDG-PET in patients with advanced stage renal cell carcinoma
por: Gilles, Rozemarie, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_igqv1qqu6f33ljgav77cqo8sob